Acute Myelogenous Leukaemia (AML)
1 clinical trials · Condition
◉ Watch Acute Myelogenous Leukaemia (AML)
| Record | Firm | Date |
|---|---|---|
| 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS (NCT00339196) | Assistance Publique - Hôpitaux de Paris | 2006-07-01 |
Track Acute Myelogenous Leukaemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.